VERVE THERAPEUTICS INC shareholders Q3 2023

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

VERVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 56,895$7540.06%
Virtus ETF Advisers LLC 5,782$76,6690.05%
PROFUND ADVISORS LLC 47,093$624,4530.04%
XTX Topco Ltd 13,169$174,6210.03%
ExodusPoint Capital Management, LP 232,620$3,0850.03%
NJ State Employees Deferred Compensation Plan 14,000$185,6400.03%
Caption Management, LLC 127,500$1,690,6500.03%
Rafferty Asset Management, LLC 319,800$4,240,5480.02%
Sumitomo Mitsui Trust Holdings, Inc. 2,147,243$28,472,4420.02%
HAP Trading, LLC 42,500$133,8750.02%
T. Rowe Price Investment Management, Inc. 2,105,298$27,9170.02%
E Fund Management Co., Ltd. 14,397$1910.02%
BOOTHBAY FUND MANAGEMENT, LLC 49,100$651,0660.02%
Jump Financial, LLC 26,913$356,8660.01%
FARALLON CAPITAL MANAGEMENT LLC 211,293$2,801,7450.01%
BOOTHBAY FUND MANAGEMENT, LLC 40,300$534,3780.01%
ALGERT GLOBAL LLC 18,022$2390.01%
Cubist Systematic Strategies, LLC 116,698$1,547,4150.01%
FMR LLC 6,577,562$87,218,4680.01%
Mirae Asset Global Investments Co., Ltd. 212,104$2,812,4990.01%
External links

This page lists VERVE THERAPEUTICS INC's shareholders in Q3 2023. To view VERVE THERAPEUTICS INC's shareholder history, click here.